-
-
-
-
-
-
-
Aprea Therapeutics (APRE) Misses Q3 EPS by 47c
-
-
-
-
-
-
-
Aprea Therapeutics (APRE) Announces Strategic IP Portfolio Evolution in DNA Damage Response (DDR) Cancer Therapeutics
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

